Cargando…

Correction to: No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter

Detalles Bibliográficos
Autores principales:	Sabazade, Shiva, Herrspiegel, Christina, Gill, Viktor, Stålhammar, Gustav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725560/ https://www.ncbi.nlm.nih.gov/pubmed/34983436 http://dx.doi.org/10.1186/s12885-021-09167-8

Ejemplares similares

No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter
por: Sabazade, Shiva, et al.
Publicado: (2021)

Vasculogenic mimicry correlates to presenting symptoms and mortality in uveal melanoma
por: Sabazade, Shiva, et al.
Publicado: (2021)

Trends in Uveal Melanoma Presentation and Survival During Five Decades: A Nationwide Survey of 3898 Swedish Patients
por: Gill, Viktor, et al.
Publicado: (2022)

Multiorgan Involvement of Dormant Uveal Melanoma Micrometastases in Postmortem Tissue From Patients Without Coexisting Macrometastases
por: Gill, Viktor T, et al.
Publicado: (2023)

Long-term relative survival in uveal melanoma: a systematic review and meta-analysis
por: Stålhammar, Gustav, et al.
Publicado: (2022)

A prognostic classification system for uveal melanoma based on a combination of patient age and sex, the American Joint Committee on Cancer and the Cancer Genome Atlas models
por: Gill, Viktor T., et al.
Publicado: (2022)

Nuclear expression of BAP-1 in transvitreal incisional biopsies and subsequent enucleation of eyes with posterior choroidal melanoma
por: Herrspiegel, Christina, et al.
Publicado: (2021)

Iris extramedullary hematopoiesis in choroidal melanoma
por: Gallo, Beatrice, et al.
Publicado: (2020)

A serum protein signature at the time of Uveal Melanoma diagnosis predicts long-term patient survival
por: Herrspiegel, Christina, et al.
Publicado: (2023)

Forty-year prognosis after plaque brachytherapy of uveal melanoma
por: Stålhammar, Gustav
Publicado: (2020)

Digital morphometry and cluster analysis identifies four types of melanocyte during uveal melanoma progression
por: Stålhammar, Gustav, et al.
Publicado: (2023)

Expression of immune checkpoint receptors Indoleamine 2,3‐dioxygenase and T cell Ig and ITIM domain in metastatic versus nonmetastatic choroidal melanoma
por: Stålhammar, Gustav, et al.
Publicado: (2019)

Author Correction: Estimation of the timing of BAP1 mutation in uveal melanoma progression
por: Uner, Ogul E., et al.
Publicado: (2021)

Variation of choroidal thickness and vessel diameter in patients with posterior non-infectious uveitis
por: Bittencourt, Millena G, et al.
Publicado: (2014)

Sex‐based differences in early and late uveal melanoma‐related mortality
por: Stålhammar, Gustav
Publicado: (2022)

Intratumor Heterogeneity in Uveal Melanoma BAP-1 Expression
por: Stålhammar, Gustav, et al.
Publicado: (2021)

Correction: Choroidal thickness assessment in keratoconus patients treated with cross-linking compared to healthy population
por: Ballesteros-Sánchez, Antonio, et al.
Publicado: (2022)

Ruthenium brachytherapy for iris melanoma
por: Zwolin´ska, Emilia, et al.
Publicado: (2023)

Correction: Time-Course of Changes in Choroidal Thickness after Complete Mydriasis Induced by Compound Tropicamide in Children
Publicado: (2017)

Unilateral acute iris transillumination syndrome with glaucoma and iris pigment epithelium dispersion simulating iris melanoma
por: Gonzalez Martinez, Orlando G., et al.
Publicado: (2023)

Iris Color and Lens Thickness in Chinese Teenagers
por: Pan, Chen-Wei, et al.
Publicado: (2018)

The Iris Thickness in a Healthy Saudi Population
por: Ziaul, Yasir H, et al.
Publicado: (2021)

Correction: Long-term complications of cosmetic iris implants
por: Queiruga-Piñeiro, Juan, et al.
Publicado: (2023)

Adjuvant melatonin for uveal melanoma (AMUM): protocol for a randomized open-label phase III study
por: Kal Omar, Ruba, et al.
Publicado: (2023)

Iris melanoma presenting as childhood glaucoma
por: Gapsis, Briana C., et al.
Publicado: (2018)

Topography and clinical features of iris melanoma
por: Krohn, Jørgen, et al.
Publicado: (2022)

Glaucoma and Choroidal Thickness
por: Jonas, Jost B.
Publicado: (2014)

The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature
por: Hagström, Anna, et al.
Publicado: (2022)

Choroidal melanoma
por: Singh, Parul, et al.
Publicado: (2012)

The prognostic implication of latitude in uveal melanoma: a nationwide observational cohort study of all patients born in Sweden between 1947 and 1989
por: Stålhammar, Gustav, et al.
Publicado: (2022)

A modified COMS plaque for iris melanoma
por: Scanderbeg, Daniel J., et al.
Publicado: (2011)

Iris melanoma in children: Current approach to management
por: McLaughlin, John P., et al.
Publicado: (2013)

Brachytherapy and anterior segment imaging in iris melanoma
por: Song, Jin Soo Andy, et al.
Publicado: (2017)

Brachytherapy and anterior segment imaging in iris melanoma
por: Song, Jin Soo Andy, et al.
Publicado: (2017)

Iris Colour and the Risk of Developing Uveal Melanoma
por: Houtzagers, Laurien E., et al.
Publicado: (2020)

Tapioca Melanoma of the Iris: A Case Report
por: Karimi, Saeed, et al.
Publicado: (2019)

Iris Ring Melanoma Presenting as Scleral Pigmentation
por: Zupan, Matej, et al.
Publicado: (2022)

The prognostic implication of visual acuity at the time of uveal melanoma diagnosis
por: Asplund, Elin, et al.
Publicado: (2022)

Locally advanced choroidal melanoma with favorable molecular prognosis – case report
por: Bălăşoiu, Andrei-Theodor, et al.
Publicado: (2022)

Choroidal thickness in obese women
por: Yumusak, Erhan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mvb1t40d20606ncds1pmb9fbfn